Prescription drug giant GlaxoSmithKline agreed to pay a record $3 billion fine to settle a litany of charges stemming from the company's illegal promotion of its products. Among other criminal complaints, federal prosecutors had accused GlaxoSmithKline of promoting the anti-depression drug Paxil for children, even though the FDA had never approved Paxil for patients under 18. GlaxoSmithKline was also accused of bribing physicians to prescribe its products, part of a web of mutual back-scratching that critics say has compromised the prescription drug market.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- 43 TV shows to watch in 2014
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- How our botched understanding of 'science' ruins everything
- The science of sex: 4 harsh truths about dating and mating
- 6 things the happiest families all have in common
- 13 Urban Outfitters controversies
- 10 things you need to know today: September 21, 2014
- This is what happens when Republicans actually enact their radical agenda
- California's epic drought
- Surviving a plane crash
Subscribe to the Week